A case of refractory ulcerative colitis treated successfully with a combination of low-dose heparin and 5-aminosalicylic acid

Japanese Journal of Gastroenterology

Volumn 100, Issue 5, 2003, Pages 567-571

  Ikehata, Atsushi ^b   Yamakawa, Mitsuru ^b   Kitagawa, Masaki ^b   Fujiwara, Takao ^b   Miura, Tatsuya ^b   Ono, Mitsuru ^a   Murakami, Akihiko ^a   Ono, Sadahide ^b   Sakuma, Tsutomu ^a  

^a Iwate Prefectural Central Hospital   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; MESALAZINE; AMINOSALICYLIC ACID DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; COLITIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; LOW DRUG DOSE; TREATMENT OUTCOME; ULCERATIVE COLITIS; DRUG ADMINISTRATION; DRUG COMBINATION;

ADULT; AMINOSALICYLIC ACIDS; COLITIS, ULCERATIVE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HEPARIN; HUMANS;

EID: 0038388853     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Gaffney PR, Doyle CT, Gaffney A, et al: Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol 1995; 90: 220-223
2. Panes J, Esteve M, Cabre E, et al: Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology 2001; 119: 903-908
3. Evans RC, Wong VS, Morris AI, et al: Treatment of corticosteroid-resistant ulcerative colitis with heparin - a report of 16 cases. Aliment Pharmacol Ther 1997; 11: 1037-1040
4. Folwaczny C, Wiebecke B, Loeschke K, et al: Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol 1999; 94: 1551-1555
5. Dotan I, Hallak A, Arber N, et al: Low-dose low-molecular weight heparin (Enoxaparin) is effective as adjuvant treatment in active ulcerative colitis. An open trial. Dig Dis Sci 2001; 46: 2239-2244
6. Wood AJJ: Low-molecular-weight heparins. N Engl J Med 1997; 337: 688-698
7. Day R, Forbes A: Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease. Lancet 1999; 354: 62-65
8. Frieri G, Pimpo MT, Palumbo GC, et al: Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment. Aliment Pharmacol Ther 1999; 13: 1413-1417
9. Safdi M, DeMicco M, Sninsky C, et al: A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Am J Gastroenterol 1997; 92: 1867-1871
10. Sawada K, Ohnishi K, Fukui S, et al: Leukocyte apheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J Gastroenterol 1995; 30: 322-329
11. Sandborn WJ: A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Am J Gastroenterol 1996; 91: 423-433